TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36229383

Group type: EXPERIMENTAL
Intervention: IV paracetamol
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: IV dexketoprofen trometamol
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Topical lidocaine
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 33878341

Group type: EXPERIMENTAL
Intervention: Text message-based intervention (3 automated messages per day for 12 weeks)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Text message-based intervention
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 42
Study: 33852743

Group type: EXPERIMENTAL
Intervention: Static loading with a crosshead speed of 0.5 mm/min
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Step‐stress cyclic loading (1 Hz) with increasing amplitude
Number of subjects: 20
Study: 32338932

Group type: EXPERIMENTAL
Intervention: Integrative cognitive‐affective therapy for BED (ICAT‐BED)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Guided self-help cognitive-behavioral therapy (CBTgsh)
Number of subjects: 112
Study: 35262490

Group type: EXPERIMENTAL
Intervention: mHealth intervention using 2 mobile apps (WeChat and Message Express) for 60 days followed by 30 days of nonintervention follow-up.
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: mHealth intervention (experimental group)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group (only received educational materials)
Number of subjects: 230
Study: 33092527

Group type: EXPERIMENTAL
Intervention: Intravesical dexmedetomidine instillation (0.5 μg/kg and normal saline 20 mL)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Normal saline (20 mL)
Number of subjects: 167
Study: 35188053

Group type: EXPERIMENTAL
Intervention: One-day DM clinic intervention (n=509)
Number of subjects: 930
Study: 34429002

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with allergen extracts of D. pteronyssinus and D. farinae (50/50%) in SQ-HDM SLIT tablets
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 32
Study: 35367007

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg every 3 weeks for 17 cycles
Number of subjects: 976

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 976
Study: 34120122

Group type: EXPERIMENTAL
Intervention: Telephone call
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: SMS
Number of subjects: 306

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 306
Study: 35279331

Group type: EXPERIMENTAL
Intervention: Classic Music Group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-Selected Group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 0
Study: 32070388

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual diet (Control) (n=15)
Number of subjects: 30
Study: 34187535

Group type: EXPERIMENTAL
Intervention: Gegen Qinlian decoction granules + Erbai drink placebo
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Erbai drink granules + Gegen Qinlian decoction placebo
Number of subjects: 120

Group type: COMPARATOR
Intervention: basic treatment + Gegen Qinlian decoction placebo + Erbai drink placebo
Number of subjects: 120
Study: 36096979

Group type: EXPERIMENTAL
Intervention: Immediate revascularization
Number of subjects: 1171

Group type: COMPARATOR
Intervention: Staged revascularization
Number of subjects: 1171
Study: 33301997

Group type: EXPERIMENTAL
Intervention: Telephone-based Management + TAU
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: iFightDepression-Survive + TAU
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Self Awareness of Mental Health + TAU
Number of subjects: 2000

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 2000
Study: 32107452

Group type: EXPERIMENTAL
Intervention: Hypertension risk-prediction model
Number of subjects: 9034
Study: 33075031

Group type: EXPERIMENTAL
Intervention: Mindful Moms intervention (12-week mindful physical activity using prenatal yoga)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindful Moms intervention
Number of subjects: 0
Study: 35577169

Group type: EXPERIMENTAL
Intervention: Daytime HRV
Number of subjects: 68

Group type: COMPARATOR
Intervention: Nighttime HRV
Number of subjects: 68

Group type: COMPARATOR
Intervention: Previous nights' sleep measures
Number of subjects: 68
Study: 33439727

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (second-line therapy)
Number of subjects: 1025
Study: 35543372

Group type: EXPERIMENTAL
Intervention: Heterologous mRNA booster (BNT162b2 + BNT162b2 + mRNA-1273; 'BBM')
Number of subjects: 100

Group type: COMPARATOR
Intervention: Homologous booster (BNT162b2 + BNT162b2 + BNT162b2; 'BBB')
Number of subjects: 100
Study: 33939794

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 8196

Group type: EXPERIMENTAL
Intervention: Current smoking (adjusted)
Number of subjects: 8196

Group type: COMPARATOR
Intervention: Former smokers
Number of subjects: 8196

Group type: COMPARATOR
Intervention: Never smokers
Number of subjects: 8196
Study: 32886108

Group type: EXPERIMENTAL
Intervention: 70 g mycoprotein (31.5 g protein; MYCO; n = 10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: 35 g BCAA-enriched mycoprotein (18.7 g protein; ENR; n = 9)
Number of subjects: 19
Study: 35916747

Group type: EXPERIMENTAL
Intervention: 60% Vmax
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 70% Vmax
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 80% Vmax
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 90% Vmax
Number of subjects: 12
Study: 34518481

Group type: EXPERIMENTAL
Intervention: Vitamin A (5,000 IU/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Vitamin A
Number of subjects: 66
Study: 33091614

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 73
Study: 32808025

Group type: EXPERIMENTAL
Intervention: Bi-anodal tDCS over the PFC regions (2 mA, 20 minutes, twice daily for 5 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 60
Study: 35039258

Group type: EXPERIMENTAL
Intervention: Combination group (erythromycin sequential therapy plus azithromycin)
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 93
Study: 32447194

Group type: EXPERIMENTAL
Intervention: PCL‐6 positive screening (score ≥14)
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: CIDI positive screening (score ≥8)
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Both PCL‐6 and CIDI positive screening
Number of subjects: 767

Group type: COMPARATOR
Intervention: PCL‐6
Number of subjects: 767

Group type: COMPARATOR
Intervention: CIDI
Number of subjects: 767
Study: 34856641

Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 33712076

Group type: EXPERIMENTAL
Intervention: Ephedrine 0.6 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ephedrine 0.8 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ephedrine 1.0 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ephedrine 1.2 mg/kg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ephedrine 1.4 mg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ephedrine 0.1 mg/kg (reference dose)
Number of subjects: 120
Study: 32112365

Group type: EXPERIMENTAL
Intervention: Propolis
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Curry leaf
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 35848821

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided 5% dextrose prolotherapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Corticosteroid injection (1 ml triamcinolone 40 mg/ml)
Number of subjects: 54
Study: 33672963

Group type: EXPERIMENTAL
Intervention: 40 g acacia gum
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 20 g acacia gum
Number of subjects: 48

Group type: COMPARATOR
Intervention: 0 g acacia gum (control)
Number of subjects: 48
Study: 32620024

Group type: EXPERIMENTAL
Intervention: Umbilical cord milking (UCM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 0
Study: 32998848

Group type: EXPERIMENTAL
Intervention: Micro‐training (4 endurance and 4 strength training sessions lasting 15 min each)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control‐training (2 sessions of standard military training lasting 60 min each)
Number of subjects: 290

Group type: COMPARATOR
Intervention: Classical‐training (1 strength and 1 endurance session lasting 60 min each)
Number of subjects: 290
Study: 33604801

Group type: EXPERIMENTAL
Intervention: Aerobic training (60 to 70% of maximal heart rate, 30 to 45 min/day, 3 sessions/week for 12 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 30
Study: 36318050

Group type: EXPERIMENTAL
Intervention: One-session treatment
Number of subjects: 268

Group type: COMPARATOR
Intervention: Cognitive-behavioural therapy
Number of subjects: 268
Study: 32385847

Group type: EXPERIMENTAL
Intervention: Mobile health intervention (CHAT) with tailored health messages
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no tailored health messages)
Number of subjects: 22
Study: 35585571

Group type: EXPERIMENTAL
Intervention: Social care nurses' continuous involvement in acute oncology wards
Number of subjects: 362

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 362
Study: 32889858

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 36107435

Group type: EXPERIMENTAL
Intervention: Commercial weight management program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Do-it-yourself (DIY) approach
Number of subjects: 0
Study: 34775994

Group type: EXPERIMENTAL
Intervention: Feedback from the Anxiety Meter
Number of subjects: 28

Group type: COMPARATOR
Intervention: No feedback from the Anxiety Meter
Number of subjects: 28
Study: 33160433

Group type: EXPERIMENTAL
Intervention: Peer Assisted Learning workshop
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (sixth year students)
Number of subjects: 104
Study: 35493437

Group type: EXPERIMENTAL
Intervention: iCT-SAD (internet Cognitive Therapy programme)
Number of subjects: 44

Group type: COMPARATOR
Intervention: waitlist control group
Number of subjects: 44
Study: 33877942

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular block (DB)
Number of subjects: 0
Study: 35600872

Group type: EXPERIMENTAL
Intervention: Tibetan herbal pain-relieving plaster (Tibetree Pain-Relieving Plaster) applied daily for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo patch applied daily for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tibetan herbal pain-relieving plaster (Tibetree Pain-Relieving Plaster)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 0
Study: 33320850

Group type: EXPERIMENTAL
Intervention: Whey protein-based multiingredient nutritional supplement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35325149

Group type: EXPERIMENTAL
Intervention: Osilodrostat
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 35032932

Group type: EXPERIMENTAL
Intervention: Digital CMV educational intervention
Number of subjects: 20
Study: 33288467

Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioral Therapy (CBT) with telephone support
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Online Cognitive Behavioral Therapy (CBT) without telephone support
Number of subjects: 638

Group type: COMPARATOR
Intervention: Online Psychoeducation
Number of subjects: 638
Study: 35179757

Group type: EXPERIMENTAL
Intervention: Standard CXL
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Accelerated CXL
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (Standard CXL)
Number of subjects: 79
Study: 33707061

Group type: EXPERIMENTAL
Intervention: 50 µg mRNA-1273
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: 100 µg mRNA-1273
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Both 50 µg and 100 µg mRNA-1273
Number of subjects: 600
Study: 36350787

Group type: EXPERIMENTAL
Intervention: CamAPS FX hybrid closed-loop (HCL)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sensor augmented pump (control)
Number of subjects: 74
Study: 32541326

Group type: EXPERIMENTAL
Intervention: Adjuvant capecitabine (for 6 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: None (control group from prospective randomized trials)
Number of subjects: 0
Study: 34439165

Group type: EXPERIMENTAL
Intervention: Neoadjuvant induction anti-HER2 therapy with lapatinib and trastuzumab followed by weekly paclitaxel plus anti-HER2 therapy.
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Patients with CpCR plus ypN0 after neoadjuvant treatment.
Number of subjects: 212
Study: 32036576

Group type: EXPERIMENTAL
Intervention: Modified ketogenic diet (MKD)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Medium chain triglyceride ketogenic diet (MCTKD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Overall trial participation
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Patient decision-making
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diet burden and quality of life
Number of subjects: 12
Study: 33866828

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 4796
Study: 35115359

Group type: EXPERIMENTAL
Intervention: Benfotiamine 300 mg two times a day for 12 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33751615

Group type: EXPERIMENTAL
Intervention: DGG + TUN
Number of subjects: 27

Group type: COMPARATOR
Intervention: SCTG + TUN
Number of subjects: 27

Group type: COMPARATOR
Intervention: SCTG samples
Number of subjects: 27
Study: 32893717

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 6820
Study: 35330577

Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery (ERAS)
Number of subjects: 49
Study: 33844575

Group type: EXPERIMENTAL
Intervention: Deferred vaccination via blinded crossover (original vaccine group receives placebo and vice versa)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo group receiving the efficacious vaccine after initial trial
Number of subjects: 0
Study: 33283550

Group type: EXPERIMENTAL
Intervention: Active magnets placed over the ulnar and median nerves at the wrist for 30 minutes.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham magnets placed at corresponding sites on the other arm for 30 minutes.
Number of subjects: 12
Study: 32165549

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation app
Number of subjects: 90

Group type: COMPARATOR
Intervention: Active control app (muscle relaxation techniques)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care without app
Number of subjects: 90
Study: 35024875

Group type: EXPERIMENTAL
Intervention: Miniscrew-facilitated micro-osteoperforations (MOPs) applied to the extraction area
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control side (no MOPs)
Number of subjects: 20
Study: 34406870

Group type: EXPERIMENTAL
Intervention: Whole breast irradiation (radiation therapy [RT])
Number of subjects: 636

Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 636
Study: 35271241

Group type: EXPERIMENTAL
Intervention: Cognitive training in addition to drug therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (drug therapy only)
Number of subjects: 60
Study: 32185662

Group type: EXPERIMENTAL
Intervention: Plecanatide 0.3 mg
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Plecanatide 3.0 mg
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Plecanatide (0.3 mg and 3.0 mg)
Number of subjects: 951

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 951
Study: 36283418

Group type: EXPERIMENTAL
Intervention: Full version of the mHealth app (Roadmap) with resilience-building activities
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control version of the mHealth app (limited view without resilience-building activities)
Number of subjects: 30
Study: 32453224

Group type: EXPERIMENTAL
Intervention: Cervical Disc Arthroplasty (CDA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anterior Cervical Discectomy and Fusion (ACDF)
Number of subjects: 0
Study: 35033928

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (liraglutide) after 10 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GLP-1 receptor agonist (liraglutide) after 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 0
Study: 33187535

Group type: EXPERIMENTAL
Intervention: Remote dietitian supervised dietary and physical activity intervention via mobile app
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clinical standard of care (nutritionist and/or physical therapy referrals)
Number of subjects: 60
Study: 35509857

Group type: EXPERIMENTAL
Intervention: Pelvic floor rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Artificial intelligence algorithm for ultrasonic image processing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (routine guidance and postpartum health education)
Number of subjects: 60
Study: 32311110

Group type: EXPERIMENTAL
Intervention: 10 mg dapagliflozin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher than 10 mg dapagliflozin
Number of subjects: 0
Study: 36052978

Group type: EXPERIMENTAL
Intervention: Capacity building program for key workers to support parental wellbeing; 12-month intervention program including tailored professional development, resource development, and sustainability measures.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 33155105

Group type: EXPERIMENTAL
Intervention: Iohexol administration at standard dose during coronary CT angiography (CCTA)
Number of subjects: 1009
Study: 32965318

Group type: EXPERIMENTAL
Intervention: Book-mediated educational intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Verbal guidance (control)
Number of subjects: 56
Study: 35367144

Group type: EXPERIMENTAL
Intervention: Virtual Reality Distraction Intervention
Number of subjects: 139
Study: 34144683

Group type: EXPERIMENTAL
Intervention: remimazolam besylate
Number of subjects: 0

Group type: COMPARATOR
Intervention: propofol
Number of subjects: 0
Study: 32142388

Group type: EXPERIMENTAL
Intervention: External focus condition (jumping towards a physical cone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imagery condition (jumping towards an imagined cone)
Number of subjects: 0
Study: 33052397

Group type: EXPERIMENTAL
Intervention: Combined intervention group
Number of subjects: 405

Group type: COMPARATOR
Intervention: Overall population
Number of subjects: 405
Study: 34130895

Group type: EXPERIMENTAL
Intervention: Biomarker measurement of tau
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Biomarker measurement of GFAP
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: NFL measured at discharge
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: GFAP measured 48 hours after induction
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: GFAP measured at discharge
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: NSE
Number of subjects: 168
Study: 33349849

Group type: EXPERIMENTAL
Intervention: Genetically decreased serum ACE levels (using genetic variants from the ORIGIN trial)
Number of subjects: 4147

Group type: EXPERIMENTAL
Intervention: Genetically decreased serum ACE levels (using genetic variants from the AGES cohort)
Number of subjects: 4147
Study: 36352558

Group type: EXPERIMENTAL
Intervention: Single-session, clinician-delivered screening and brief intervention (SBI)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control
Number of subjects: 143
Study: 34900443

Group type: EXPERIMENTAL
Intervention: Manual Therapy+Exercise (MT+Exercise) Group
Number of subjects: 58

Group type: COMPARATOR
Intervention: Exercise Group
Number of subjects: 58
Study: 35078205

Group type: EXPERIMENTAL
Intervention: Painful (nociceptive stimulation)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Painless (non‐nociceptive stimulation)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 36
Study: 34023199

Group type: EXPERIMENTAL
Intervention: Radiomics model established using five features
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Combination model incorporating radiomics signature with two clinical biomarkers
Number of subjects: 108
Study: 33299555

Group type: EXPERIMENTAL
Intervention: MCT/LCT/OO/FO IVLE
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard IVLE
Number of subjects: 12
Study: 33754803

Group type: EXPERIMENTAL
Intervention: Transcatheter AVR with AF at discharge
Number of subjects: 2663

Group type: EXPERIMENTAL
Intervention: Transcatheter AVR with SR/AF
Number of subjects: 2663

Group type: EXPERIMENTAL
Intervention: Surgical AVR with AF at discharge
Number of subjects: 2663

Group type: EXPERIMENTAL
Intervention: Transcatheter AVR and Surgical AVR with AF at discharge
Number of subjects: 2663

Group type: EXPERIMENTAL
Intervention: Transcatheter AVR cohort
Number of subjects: 2663
Study: 32925344

Group type: EXPERIMENTAL
Intervention: Processed EEG-guided anesthetic management to keep the Patient State Index (PSI) above 35
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard care (EEG data blinded from clinicians)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Processed EEG-guided anesthetic management
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 204
Study: 33291998

Group type: EXPERIMENTAL
Intervention: Personalized feedback on behaviours that elicit positive emotions (PA)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Self-monitoring only
Number of subjects: 72